مقال بحثي وصول مفتوح
Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome
Two infants with retinoblastoma and 13q syndrome with multiorgan system anomalies were treated with targeted intra-arterial chemotherapy (IAC) using one-to-three cycles of melphalan 5 mg to avoid systemic chemotherapeutic side effects. Both patients showed good response, with tumor control and no systemic chemotherapy …